Regenerative Medical Technology Group Inc.
Regenerative Medical Technology Group Inc. operates in the regenerative medicine industry in the United States and internationally. It provides products, solutions, equipment, services, and training to doctors and their staff in the application of stem cell therapies. The company is also involved in the treatment of patients; provision of training and seminars; and resale of kits, products, equip… Read more
Regenerative Medical Technology Group Inc. (RMTG) - Total Assets
Latest total assets as of September 2025: $4.52 Million USD
Based on the latest financial reports, Regenerative Medical Technology Group Inc. (RMTG) holds total assets worth $4.52 Million USD as of September 2025.
Total assets represent everything the company owns and controls, combining both current assets—like cash and cash equivalents, accounts receivable, and inventories—and non-current assets such as property, plant, equipment (PP&E), intangible assets, and long-term investments.
Regenerative Medical Technology Group Inc. - Total Assets Trend (2014–2024)
This chart illustrates how Regenerative Medical Technology Group Inc.’s total assets have evolved over time, based on quarterly financial data. Explore and compare other companies by total assets.
Regenerative Medical Technology Group Inc. - Asset Composition Analysis
Current Asset Composition (December 2024)
Regenerative Medical Technology Group Inc.'s total assets of $4.52 Million consist of 32.7% current assets and 67.3% non-current assets.
| Asset Category | Amount (USD) | % of Total Assets |
|---|---|---|
| Cash & Equivalents | $0.00 | 30.5% |
| Accounts Receivable | $22.61K | 0.6% |
| Inventory | $10.12K | 0.3% |
| Property, Plant & Equipment | $0.00 | 0.0% |
| Intangible Assets | $159.00K | 4.2% |
| Goodwill | $1.68 Million | 44.0% |
Asset Composition Trend (2014–2024)
This chart illustrates how Regenerative Medical Technology Group Inc.'s asset composition has evolved over time. Understanding changes in asset allocation can provide insights into the company's strategic shifts, capital allocation priorities, and business focus evolution.
Key Asset Composition Facts
- Current vs. Non-Current Assets: Regenerative Medical Technology Group Inc.'s current assets represent 32.7% of total assets in 2024, an increase from 0.0% in 2014.
- Cash Position: Cash and equivalents constituted 30.5% of total assets in 2024, up from 0.0% in 2014.
- Tangible vs. Intangible: Intangible assets (including goodwill) make up 47.0% of total assets, an increase from 7.0% in 2014.
- Asset Diversification: The largest asset category is goodwill at 44.0% of total assets.
Regenerative Medical Technology Group Inc. Competitors by Total Assets
Key competitors of Regenerative Medical Technology Group Inc. based on total assets are shown below.
| Company | Country | Total Assets |
|---|---|---|
|
MedPacto Inc
KQ:235980
|
Korea | ₩51.58 Billion |
|
2H0
F:2H0
|
Germany | €15.27 Million |
|
Shenzhen CAU Technology Co Ltd
SHE:000004
|
China | CN¥260.55 Million |
|
Pacific Shuanglin Bio pharmacy Co Ltd
SHE:000403
|
China | CN¥9.58 Billion |
|
Nanhua Bio Medicine Co Ltd
SHE:000504
|
China | CN¥841.96 Million |
|
Jiangsu Sihuan Bioengineering Co Ltd
SHE:000518
|
China | CN¥509.14 Million |
|
Chengzhi Shareholding Co Ltd
SHE:000990
|
China | CN¥27.52 Billion |
|
Hualan Biological EngineeringInc
SHE:002007
|
China | CN¥16.27 Billion |
Regenerative Medical Technology Group Inc. - Asset Efficiency Metrics
Asset efficiency metrics measure how effectively a company uses its assets to generate revenue and profits. These indicators help investors evaluate management's ability to deploy capital efficiently.
Asset Turnover Ratio
Measures how efficiently a company uses its assets to generate sales
Strong asset utilization - Regenerative Medical Technology Group Inc. generates 1.07x its asset value in annual revenue.
Return on Assets (ROA)
Measures how efficiently a company uses its assets to generate profits
Negative ROA - Regenerative Medical Technology Group Inc. is currently not profitable relative to its asset base.
Regenerative Medical Technology Group Inc. - Liquidity and Working Capital Analysis
Liquidity ratios measure a company's ability to pay off its short-term debts as they come due, using the company's current or quick assets. Working capital represents the operational liquidity available.
Key Liquidity Metrics
| Metric | Current | 1 Year Ago | 5 Years Ago |
|---|---|---|---|
| Current Ratio | 0.09 | 0.03 | 0.00 |
| Quick Ratio | 0.08 | 0.03 | 0.00 |
| Cash Ratio | 0.00 | 0.00 | 0.00 |
| Working Capital | $-15.76 Million | $ -26.58 Million | $ -6.94 Million |
Regenerative Medical Technology Group Inc. - Advanced Valuation Insights
This section examines the relationship between Regenerative Medical Technology Group Inc.'s asset base and its market valuation, helping to identify whether the company's assets are efficiently translated into market value.
Key Valuation Metrics
| Current Price-to-Book Ratio | - |
| Latest Market Cap to Assets Ratio | 0.10 |
| Asset Growth Rate (YoY) | 32.7% |
| Total Assets | $3.82 Million |
| Market Capitalization | $368.49K USD |
Valuation Analysis
Below Book Valuation: The market values Regenerative Medical Technology Group Inc.'s assets below their book value (0.10 x), which may indicate investor concerns about asset quality or future growth.
Rapid Asset Growth: Regenerative Medical Technology Group Inc.'s assets grew by 32.7% over the past year, indicating significant expansion of the company's resource base.
Annual Total Assets for Regenerative Medical Technology Group Inc. (2014–2024)
The table below shows the annual total assets of Regenerative Medical Technology Group Inc. from 2014 to 2024.
| Year | Total Assets | Change |
|---|---|---|
| 2024-12-31 | $3.82 Million | +32.73% |
| 2023-12-31 | $2.88 Million | -64.37% |
| 2022-12-31 | $8.08 Million | -13.17% |
| 2021-12-31 | $9.31 Million | +4134.92% |
| 2020-12-31 | $219.73K | +534.45% |
| 2018-12-31 | $34.63K | +340.69% |
| 2017-12-31 | $7.86K | -48.30% |
| 2016-12-31 | $15.20K | -94.96% |
| 2015-12-31 | $301.65K | -89.58% |
| 2014-12-31 | $2.89 Million | -- |